Pelger–Huet anomaly

Pelger–Huët anomaly
Classification and external resources
Specialty hematology
ICD-10 D72.0
ICD-9-CM 288.2
OMIM 169400
DiseasesDB 29515
eMedicine ped/1753
MeSH D010381

Pelger–Huët anomaly (pronunciation: [pel′gər hyo̅o̅′ət]) is a blood laminopathy associated with the lamin B receptor.[1]

It is characterized by a white blood cell type known as a neutrophil whose nucleus is hyposegmented.

Pelger–Huët anomaly has an autosomal dominant pattern of inheritance.

It is a genetic disorder with an autosomal dominant inheritance pattern. Heterozygotes are clinically normal, although their neutrophils may be mistaken for immature cells which may cause mistreatment in a clinical setting. Homozygotes tend to have neutrophils with rounded nuclei that do have some functional problems.

Congenital Pelger–Huët anomaly

Is a benign dominantly inherited defect of terminal neutrophil differentiation as a result of mutations in the lamin B receptor gene. The characteristic leukocyte appearance was first reported in 1928 by Pelger, a Dutch hematologist, who described leukocytes with dumbbell-shaped bilobed nuclei, a reduced number of nuclear segments, and coarse clumping of the nuclear chromatin. In 1931 Huet, a pediatrician, identified it as an inherited disorder.[2]

It is a genetic disorder with an autosomal dominant inheritance pattern.[1][3] Heterozygotes are clinically normal, although their neutrophils may be mistaken for immature cells, which may cause mistreatment in a clinical setting. Homozygotes tend to have neutrophils with rounded nuclei that do have some functional problems. Homozygous individuals inconsistently have skeletal anomalies such as post-axial polydactyly, short metacarpals, short upper limbs, short stature, or hyperkyphosis.

Identifying Pelger–Huët anomaly is important to differentiate from bandemia with a left-shifted peripheral blood smear and neutrophilic band forms and from an increase in young neutrophilic forms that can be observed in association with infection.

Acquired or pseudo-Pelger–Huët anomaly

Anomalies resembling Pelger–Huët anomaly that are acquired rather than congenital have been described as pseudo Pelger–Huët anomaly. These can develop in the course of acute myelogenous leukemia or chronic myelogenous leukemia and in myelodysplastic syndrome. It has also been described in Filovirus disease.[4]

In patients with these conditions, the pseudo–Pelger–Huët cells tend to appear late in the disease and often appear after considerable chemotherapy has been administered. The morphologic changes have also been described in myxedema associated with panhypopituitarism, vitamin B12 and folate deficiency, multiple myeloma, enteroviral infections, malaria, muscular dystrophy, leukemoid reaction secondary to metastases to the bone marrow, and drug sensitivity, sulfa and valproate toxicities[5] are examples. In some of these conditions, especially the drug-induced cases, identifying the change as Pelger–Huët anomaly is important because it obviates the need for further unnecessary testing for cancer.

Peripheral blood smear shows a predominance of neutrophils with bilobed nuclei which are composed of two nuclear masses connected with a thin filament of chromatin. It resembles the pince-nez glasses, so it is often referred to as pince-nez appearance. Usually the congenital form is not associated with thrombocytopenia and leukopenia, so if these features are present more detailed search for myelodysplasia is warranted, as pseudo-Pelger–Huët anomaly can be an early feature of myelodysplasia.[6]

References

  1. 1 2 Hoffmann, Katrin; Dreger, Christine K.; Olins, Ada L.; Olins, Donald E.; Shultz, Leonard D.; Lucke, Barbara; Karl, Hartmut; Kaps, Reinhard; Müller, Dietmar; Vayá, Amparo; Aznar, Justo; Ware, Russell E.; Cruz, Norberto Sotelo; Lindner, Tom H.; Herrmann, Harald; Reis, André; Sperling, Karl (2002). "Mutations in the gene encoding the lamin B receptor produce an altered nuclear morphology in granulocytes (Pelger–Huët anomaly)". Nature Genetics 31 (4): 410–4. doi:10.1038/ng925. PMID 12118250.
  2. Cunningham, John M.; Patnaik, Mrinal M.; Hammerschmidt, Dale E.; Vercellotti, Gregory M. (2009). "Historical perspective and clinical implications of the Pelger-Huet cell". American Journal of Hematology 84 (2): 116–9. doi:10.1002/ajh.21320. PMID 19021122.
  3. Vale, A. M.; Tomaz, L. R.; Sousa, R. S.; Soto-Blanco, B. (2011). "Pelger-Huët anomaly in two related mixed-breed dogs". Journal of Veterinary Diagnostic Investigation 23 (4): 863–5. doi:10.1177/1040638711407891. PMID 21908340.
  4. Gear, JS; Cassel, GA; Gear, AJ; Trappler, B; Clausen, L; Meyers, AM; Kew, MC; Bothwell, TH; Sher, R; Miller, GB; Schneider, J; Koornhof, HJ; Gomperts, ED; Isaäcson, M; Gear, JH (1975). "Outbreake of Marburg virus disease in Johannesburg". British Medical Journal 4 (5995): 489–93. doi:10.1136/bmj.4.5995.489. PMC 1675587. PMID 811315.
  5. Singh, Nishith K.; Nagendra, Sanjai (2008). "Reversible Neutrophil Abnormalities Related to Supratherapeutic Valproic Acid Levels". Mayo Clinic Proceedings 83 (5): 600. doi:10.4065/83.5.600. PMID 18452694.
  6. Pelger-Huet Anomaly at eMedicine
This article is issued from Wikipedia - version of the Monday, March 21, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.